Team Metabolic Health AstraZeneca (AZN.L), opens new tab said on Monday its experimental weight-loss pill, licensed a year ago from China’s Eccogene for up to $2 billion, was safe and tolerable in an early-stage trial, with side effects consistent with the GLP-1 drug class. Sharon Barr, executive vice president of biopharmaceuticals R&D, said AstraZeneca had […]

Team Metabolic Health Popular weight-loss drug Wegovy maker Novo Nordisk (NOVOb.CO) expects high demand and acceptance for its anti-obesity drug, when launched in India, a top executive said. The company is still “evaluating” the price of the drug, but is confident that the price-sensitive Indian population will be able to afford it, Novo’s India Managing […]

Team Metabolic Health Novo Nordisk (NOVOb.CO), opens new tab said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 drugs already on the market, and reiterated its expectation the new injection will deliver 25% weight loss. Martin Holst Lange, Novo Nordisk’s head of development, made the […]

Team Metabolic Health Novo Nordisk (NOVOb.CO), opens new tab is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply in that market, its CEO said on Wednesday. “In our guidance for the full year, you can assume that there is a step up in the fourth quarter […]

Team Metabolic Health New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility and pain relief.  In a recent study published in The New England Journal of Medicine, researchers used a 68-week-long, extensive (61 centers across 11 countries), randomized clinical trial to evaluate Semaglutide’s pain- and weight-relieving performance in overweight arthritis […]

Team Metabolic Health Semaglutide linked to 40-70% lower risk of first-time Alzheimer’s diagnosis in type 2 diabetes patients compared to other antidiabetic medications.  A recent Alzheimer’s and Dementia study uses real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s disease (AD). Could semaglutide prevent AD? In 2014, approximately 6.9 million American […]

Team Metabolic Health Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds. People taking this class of drugs, called glucagon-like peptide-1 receptor agonists (GLP-1), have a 50% lower rate of drunkenness than people with addiction disorders not on the meds, researchers reported […]

Team Metabolic Health Decisions on how these drugs will be used look likely to shape our future health and even what our society might look like. And, as researchers are finding, they are already toppling the belief that obesity is simply a moral failing of the weak-willed. Weight-loss drugs are already at the heart of […]

Team Metabolic Health Glucagon-like peptide-1 (GLP-1) agonists have taken the healthcare world by storm, emerging as mainstream treatments for patients with diabetes or obesity. Some of these medications include Novo Nordisk’s (NYSE: NVO) Ozempic, Wegovy, Rybelsus, and Saxenda, and Eli Lilly’s (NYSE: LLY) Mounjaro and Zepbound. Below, I’ll dig into which pharmaceutical stock I think is the better buy for the […]

Team Metabolic Health Novo Nordisk (NOVOb.CO), opens new tab said on Friday its weight-loss drug met the main goal of a late-stage trial in patients with a type of fatty liver disease by reducing scarring of the organ without worsening the condition. The study used 2.4 milligram dose of semaglutide to treat a liver condition […]

Team Metabolic Health In a practice-changing guideline reversal, medical societies advised, opens new tab on Tuesday that most patients do not need to stop taking GLP-1 diabetes and weight-loss drugs before surgery, a ruling supported by a study presented this week at a medical meeting of gastrointestinal doctors. The study also suggests that patients might benefit from […]

Team Metabolic Health Teva described the EU regulator’s decision as “extreme, untested and factually unsupported.” The European Commission has hit the world’s largest maker of generic drugs with a €462.6 million fine for breaching the bloc’s competition rules. It is the first time in the history of the EU’s antitrust division that a company has been […]

Team Metabolic Health Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro and Orsema, developed by a little-known Bangladeshi drugmaker, Incepta Pharmaceuticals. The injectable pens, 14 of which were seized at the border, contained semaglutide, a patented substance that helps control blood sugar levels and appetite […]

Team Metabolic Health Acupuncture eases leg pain caused by a herniated disk Acupuncture can alleviate pain and improve function in patients with chronic sciatica from a herniated disk, according to a Chinese study. At six hospitals in China, researchers recruited 216 patients with herniated disks causing sciatica for at least three months and randomly assigned […]

Team Metabolic Health Participants exposed to arsenic levels at or above the EPA limit had a 42% higher risk of ischemic heart disease, while even moderate exposure increased risk by 20%.  Study: Gut microbiome dysbiosis is associated with lumbar degenerative spondylolisthesis in symptomatic patients. Image Credit: CandyRetriever/Shutterstock.com In a recent study published in the Environmental Health Perspectives, a group […]